CervoMed Inc. — Director's Dealing 2014

Jun 12, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RestorGenex Corp (RESX)
CIK: 0001053691
Period of Report: 2014-06-03

Reporting Person: Abolin Craig (VP of Research & Dev - Subsid.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-03	Stock Option (right to buy)	$4.15	A	57596	Acquired	2019-06-02	Common Stock (57596)	Direct

Footnotes

F1: The option will vest in equal quarterly installments for three years following the date of grant.